BiotechTube
PictorLabs

PictorLabs

San Francisco, United States· Est.
pictorlabs.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PictorLabs is an AI-powered digital pathology company founded in 2020 that has developed a validated virtual staining platform. Its core technology, including DeepStain™, ReStain, and ClearStain™, uses advanced machine learning to create H&E-equivalent and multiplex stains digitally, delivering results in minutes instead of days. This approach addresses critical pain points in pathology labs, including slow turnaround times, tissue consumption, and workflow inefficiencies, positioning the company as an enabler for the broader digital pathology transition. Backed by notable investors and led by a team with deep expertise in life sciences and engineering, PictorLabs is commercializing its software solutions for integration into existing laboratory systems.

Oncology

Technology Platform

AI-powered virtual staining platform that uses machine learning to generate diagnostic-quality digital stains (e.g., H&E-equivalent, multiplex) from tissue images in minutes, eliminating chemical processing.

Opportunities

The rapid global adoption of digital pathology creates a massive addressable market for workflow acceleration tools.
The growing need for multiplex tissue analysis in research and diagnostics aligns perfectly with PictorLabs' tissue-preserving technology, opening opportunities in biopharma R&D and companion diagnostics.

Risk Factors

Key risks include slow adoption in the conservative pathology field, intense competition from both startups and large medtech companies, and the ongoing challenge of validating AI models to meet stringent regulatory and clinical accuracy standards across diverse tissue types and scanners.

Competitive Landscape

PictorLabs competes in the AI-powered digital pathology space against other specialized startups (e.g., PathAI, Paige) and the internal development efforts of large, established players like Roche, Philips, and Leica, who control the scanner and workflow ecosystem. Differentiation hinges on staining accuracy, workflow integration ease, and validation breadth.

More companies in AI / Machine Learning →More companies in United States →